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Abstract
Background: Sirtuin 3 (SIRT3) is one of the seven mammalian sirtuins, which are homologs of the yeast Sir2 gene. SIRT3 is
the only sirtuin with a reported association with the human life span. Peroxisome proliferator-activated receptor c
coactivator-1a (PGC-1a) plays important roles in adaptive thermogenesis, gluconeogenesis, mitochondrial biogenesis and
respiration. PGC-1a induces several key reactive oxygen species (ROS)-detoxifying enzymes, but the molecular mechanism
underlying this is not well understood.
Results: Here we show that PGC-1a strongly stimulated mouse Sirt3 gene expression in muscle cells and hepatocytes.
Knockdown of PGC-1a led to decreased Sirt3 gene expression. PGC-1a activated the mouse SIRT3 promoter, which was
mediated by an estrogen-related receptor (ERR) binding element (ERRE) (2407/2399) mapped to the promoter region.
Chromatin immunoprecipitation and electrophoretic mobility shift assays confirmed that ERRa bound to the identified ERRE
and PGC-1a co-localized with ERRa in the mSirt3 promoter. Knockdown of ERRa reduced the induction of Sirt3 by PGC-1a in
C2C12 myotubes. Furthermore, Sirt3 was essential for PGC-1a-dependent induction of ROS-detoxifying enzymes and several
components of the respiratory chain, including glutathione peroxidase-1, superoxide dismutase 2, ATP synthase 5c, and
cytochrome c. Overexpression of SIRT3 or PGC-1a in C2C12 myotubes decreased basal ROS level. In contrast, knockdown of
mSIRT3 increased basal ROS level and blocked the inhibitory effect of PGC-1a on cellular ROS production. Finally, SIRT3
stimulated mitochondrial biogenesis, and SIRT3 knockdown decreased the stimulatory effect of PGC-1a on mitochondrial
biogenesis in C2C12 myotubes.
Conclusion: Our results indicate that Sirt3 functions as a downstream target gene of PGC-1a and mediates the PGC-1a
effects on cellular ROS production and mitochondrial biogenesis. Thus, SIRT3 integrates cellular energy metabolism and ROS
generation. The elucidation of the molecular mechanisms of SIRT3 regulation and its physiological functions may provide a
novel target for treating ROS-related disease.
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Introduction
Peroxisome proliferator-activated receptor c (PPARc) coacti-
vator-1a (PGC-1a) was originally identified as a cold-inducible
transcriptional coactivator of PPARc. Recent studies show that
PGC-1a plays important roles in adaptive thermogenesis in
skeletal muscle and brown fat, gluconeogenesis in liver, mito-
chondrial biogenesis and respiration in muscle cells, and heart
development [1,2]. Notably, PGC-1a potently induces the
expression of genes implicated in energy homeostasis in almost
every cell type through interacting directly with and coactivating
known mitochondrial regulators, such as the estrogen related
receptors (ERRs), PPARs, or nuclear respiratory factors (NRFs)
[1,2,3,4]. Overexpression of PGC-1a in skeletal muscle cells results
in increased energy expenditure and mitochondrial biogenesis
[5,6]. PGC-1a is induced in mouse liver by fasting and regulates
the expression of several key genes involved in gluconeogenesis,
including phosphoenolpyruvate carboxykinase and glucose-6-
phosphatase [7,8]. PGC-1a knockout mice exhibit multiple
metabolic defects, such as obesity, neurodegeneration and
cardiomyopathy [9,10].
Reactive oxygen species (ROS) can react with DNA, proteins
and lipids and play important roles in many physiological and
pathophysiological conditions, such as diabetes, neurodegenerative
diseases, cancer, and aging [11]. Although ROS are produced
in multiple cell compartments, the majority of cellular ROS
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olism. The mitochondrial electron transport chain complex I and
complex III are presumed to be major sites of ROS generation
[11], where electrons escape the electron transport chain and react
with molecular oxygen, leading to the generation of superoxide.
There are two main ways in which ROS production is limited in
vivo. The first is through the action of detoxifying enzymes,
including glutathione peroxidase-1 (GPx1) and superoxide dis-
mutases (SODs). The second is through the uncoupling proteins
[12,13]. Although PGC-1a stimulates mitochondrial biogenesis
and electron transport activity, it suppresses ROS production and
protects neural cells from oxidative stressor-induced death through
the induction of several key ROS-detoxifying enzymes. PGC-1a
null mice are more sensitive to the neurodegenerative effects of
oxidative stress [14].
ERRs are a family of orphan nuclear hormone receptors
consisting of ERRa, ERRb, and ERRc [15]. The ERRs share
high sequence similarity to the estrogen receptor [16]. ERRa is
expressed in various tissues and participates in metabolic
regulation. ERRa null mice are resistant to obesity induced by a
high-fat diet and exhibit reduced lipogenesis in their adipose tissue
[17]. ERRa not only is a downstream target of PGC-1a but also is
coactivated by this transcriptional coactivator. Consistent with the
ability of PGC-1a to induce ERRa activity and expression, these
proteins both control broad aspects of mitochondrial biology,
including mitochondrial biogenesis, fatty acid oxidation, and
oxidative respiration [18,19,20].
Sirt3 is a member of the class III histone deacetylases, also
referred to as sirtuins (SIRTs). The SIRTs are a conserved family
of proteins possessing NAD
+-dependent deacetylase activity,
distinct from class I and II histone deacetylases. SIRTs also
possess ADP-ribosyltransferase activity. SIRTs have been demon-
strated to play important roles in many physiological and
pathophysiological conditions, including metabolism, cell survival,
cancer, aging and calorie restriction-mediated longevity of
organisms ranging from yeasts to humans [21,22]. Acetyl-CoA
synthetase 2 (AceCS2), a mitochondrial enzyme that converts
acetate into acetyl-CoA, was the first mitochondrial substrate of
SIRT3 identified [23,24]. Deacetylation of AceCS2 at lysine 642
by SIRT3 activates acetyl-CoA synthetase activity, providing
increased acetyl-CoA to feed into the tricarboxylic acid cycle.
Glutamate dehydrogenase (GDH) and a component of complex I
named NDUFA9, both mitochondrial proteins involved in energy
production, are deacetylated by SIRT3 [25,26]. Ku70 and
forkhead transcription factor Foxo3a are also substrates of SIRT3
[27,28,29]. Sirt3-deficient animals exhibit striking mitochondrial
protein hyperacetylation, suggesting that SIRT3 is a major
mitochondrial deacetylase [25]. Remarkably, the basal levels of
ATP in the heart, kidney and liver of SIRT3 null mice are reduced
more than 50%, suggesting SIRT3 plays a role in regulating
energy homeostasis in vivo [26]. In addition, variability in the
human SIRT3 (hSIRT3) gene was reported to be linked to human
longevity [30,31].
Human SIRT3 is a mitochondrial protein, and its N-terminal
25 amino acid residues are responsible for its mitochondrial
localization [32,33]. Human SIRT3 is synthesized as an inactive
protein and is activated by matrix peptidase [33]. However, mouse
Sirt3 (mSirt3) was initially reported to encode a 257 amino acid
protein (approximately 28 kDa) that aligned well with the C-
terminal portion of hSIRT3 (residues 143–399) [34]. Although the
originally predicted mSIRT3 lacks the N-terminal 142 amino
acids responsible for the mitochondrial localization of the human
counterpart, it has still been shown to be localized in mitochondria
[35]. In two recent studies, however, two longer forms of mouse
SIRT3 (approximately 37 kDa) owning the mitochondrial target
signal, were detected [36,37].
Mouse SIRT3 is highly expressed in various tissues with high
energy demands, including brain, kidney, heart and liver. Mouse
SIRT3 expression is up-regulated by caloric restriction and cold
exposure, and overexpression of mSIRT3 in adipocytes leads to
the induction of genes involved in mitochondrial function and
thermogenesis [35]. However, little else is currently known about
the molecular mechanism of the regulation of Sirt3 gene
expression.
Here we show that PGC-1a powerfully stimulates mSIRT3
gene expression, which is mediated by an ERR binding element
mapped to the Sirt3 promoter region. Furthermore, we demon-
strate that SIRT3 is required for the effects of PGC-1a on
mitochondrial-related gene expression, ROS production and
mitochondrial biogenesis in muscle cells.
Materials and Methods
Plasmids and Adenoviruses
The mSirt3 promoter (22036 to +146) was amplified as
described previously [34] using mouse genomic DNA and cloned
at the Acc65 I and Xho I sites of the pGL3-Basic reporter gene
vector (Promega), referred to as Luc-2036. Various fragments of
the 59 flanking promoter region of mSIRT3 were generated by
PCR amplification of Luc-2036 followed by cloning into pGL3-
Basic using the Acc65 I and Xho I sites. To amplify different
promoter regions, the corresponding forward primers 59-
ATTCGGGGTACCATCCAATCCCGGTCTGGTCTAC-39
(Luc-2036), 59- ACATTGGTACCAGCGTCCCACTAGCCT-
CACGGGT-39 (Luc-491), 59- ATTCAGGGTACCCAAGGAG-
GTCGAGAGCGGCGT-39 (Luc-242), and 59- ATTCAGGG-
TACCGCTGCCAGCACCAGGCA-39 (Luc-161) were used with
the identical reverse primer 59- ATTCAGCTCGAGCTATC-
TGCGAGATCCCGTGTCT-39 (+146 bp). Site-directed muta-
genesis was performed using the QuickChange kit (Stratagene, La
Jolla, CA) according to the manufacturer’s protocol. pcDNA3.1-
PGC-1a for the expression of human full-length PGC-1a was a gift
from Daniel P. Kelly (Washington University School of Medicine,
St. Louis, Missouri, USA). Adenoviral vectors expressing GFP,
PGC-1a,o rE R R a were generated using the AdEasy system as
previously described [38]. The adenoviral vector expressing short-
hairpin RNAs (shRNAs) against ERRa (siERRa) was a kind gift
from Dr. Anastasia Kralli (Department of Cell Biology, The Scripps
Research Institute, La Jolla, California), which targets the sequence
59-GAGCATCCCAGGCTTCTCC-39 of mouse ERRa [39].
The sequence of siRNA against luciferase (siControl) was 59-
CTTACGCTGAGTACTTCGA-39; the sequence of siRNA
against mSirt3 (siSIRT3) was 59- GCGTTGTGAAACCCGACAT
-39; and the sequence of siRNA against mouse PGC-1a (siPGC-1a)
was 59- GGTGGATTGAAGTGGTGTAGA-39 [40]. Inserts were
cloned into the pAdTrack-U6 shuttle vector using Bgl II and Hind
III, and adenovirus constructs were created by recombination of the
shuttle vector and pAdEasy vector by electroporation into BJ5183
bacteria [41]. All plasmid constructs were verified by sequencing.
Cell Culture and Adenoviral Infection
Human embryonic kidney (HEK) 293A, HepG2, and C2C12
cell lines from ATCC were maintained in DMEM supplemented
with 10% fetal bovine serum (FBS) and antibiotics. Myotube
differentiation was induced as previously reported [42]. Primary
mouse hepatocytes were obtained from livers of male C57BL/6
mice by collagenase perfusion as previously described [43]. All
animal experiments were carried out under protocols approved by
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Medical Science in Beijing and were in accordance with Peking
Union Medical College guidelines. Mouse hepatocytes were
cultured in RPMI-1640 containing 10% FBS. Mouse hepatocytes
and C2C12 myotubes were infected with adenoviruses of interest.
Cells were harvested 48 h after infection to perform the various
measurements.
Luciferase Assays
HepG2 cells were cultured in 24-well plates and cotransfected
with PGC-1a plasmid (0.2 mg/well), ERRa plasmid (0.2 mg/well),
luciferase reporter construct (0.2 mg/well), and pRL-TK reporter
plasmid (control reporter) (0.006 mg/well) according to the
manufacturer’s protocol (Vigorous, Beijing, China), or cells were
infected with adenovirus expressing control shRNA or shRNA
against ERRa. The mass of transfected plasmids was balanced
with empty vector (pcDNA3.1). After transfection for 48 h, cells
were harvested and measured using the Dual-Luciferase Reporter
assay system (Promega), and luciferase activity was divided by the
Renilla luciferase activity (control reporter) to normalize for
transfection efficiency. All luciferase assay experiments were
performed 3 times at least, and each conducted in triplicate.
Electrophoretic Mobility Shift Assays (EMSA)
EMSA was carried out using the LightShift Chemiluminescent
EMSA Kit (Pierce) as previously described [44]. Briefly, 293A cells
were cultured in 100 mm dishes and then transfected with ERRa
expressing plasmid (10 mg). After 24 h, the nuclear proteins were
extracted according to the manufacturer’s protocol (Pierce). The
sequence of the wild-type oligonucleotide SIRT3-ERRE-WT was
59- Biotin-GGTTTCTGGCCCTGCCCTTGAGGCATTA AA-
GAG-39, whereas the sequence of the mutant oligonucleotide
SIRT3-ERRE-mut was 59- GGTTTCTGGCCCTGtaaTT-
GAGGCATTAAAGAG-39. Equal amounts of complementary
oligonucleotides were annealed. Biotin-labeled probes and protein
were combined in a total volume of 20 ml reaction buffer. In
competition analysis, a 200-fold excess of unlabeled competitor
DNA was added to the reaction mixture. After pre-incubation for
10 min at room temperature, 20 fmol of biotin end-labeled probe
was added, and the incubation was continued for an additional
20 min. The protein-DNA complexes were then resolved in a
nondenaturing 6% acrylamide gel in 0.56TBE buffer at 100 V.
After electrophoresis, the gel and nylon membrane were
sandwiched in a clean electrophoretic transfer unit according the
manufacturer’s instructions at 380 mA for 60 min. When the
transfer was completed, transferred DNA was immediately cross-
linked to the membrane at 120 mJ/cm
2 for 60 seconds.
Afterward, biotin-labeled DNA was detected by chemilumines-
cence reagent.
Chromatin Immunoprecipitation Assays
Mouse hepatocytes were extracted or infected with adenoviruses
expressing FLAG-tagged ERRa, PGC-1a or GFP as a control.
After 48 h, cells were harvested in PBS and cross-linked with 1%
formaldehyde, lysed, and subjected to chromatin shearing by
sonication. Immunoprecipitation was carried out with anti-PGC-
1a (Calbiochem) or M2 anti-FLAG antibody or normal mouse
IgG (Sigma), followed by incubation with protein G-Sepharose.
After chromatin immunoprecipitation, DNA was purified by
phenol/chloroform extraction. PCR analysis was performed with
input (2% of total immunoprecipitation) and immunoprecipitated
DNA. The primers were designed to amplify the region 2491 to
2319 bp of the mouse SIRT3 promoter containing an ERR
binding site: 59-AGCGTCCCACTAGCCTCACGGGTTG-39
(forward) and 59-GAGGACCCAAGTCTGCAGGCTTGAG-39
(reverse). The primers for the distal region (from 21400 to
21271 bp) of the mouse Sirt3 promoter were 59-GAGACA-
GCGTCAACTCCCACTC-39 (forward) and 59-CCAATGCCT-
TCAAGGCTGAAG-39 (reverse).
RNA isolation and Quantitative Real-Time PCR
Total RNA from cultured cells was extracted using TRIzol
reagent (Invitrogen). cDNA was then reverse-transcribed and
amplified by PCR using a Transcriptor Reverse Transcriptase kit
(Roche). Quantitative RT-PCR was carried out using the SYBR
Green PCR system on a Bio-Rad iQ5, and results were
normalized to b-actin or cyclophilin A. The sequences of primers
are shown in table 1.
Western blotting
C2C12 myotubes were cultured in 60 mm dishes, infected with
adenoviruses and, 48 h later, lysed in 100 ml of lysis buffer (50 mM
Tris, pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.25% sodium
deoxycholate, and 1% NP40) containing protease inhibitors
Table 1. Primer details.
primer forward (59-39) reverse (59-39)
Mouse sirt3 GCTGCTTCTGCGGCTCTATAC GAAGGACCTTCGACAGACCGT
Human sirt3 CGGCTCTACACGCAGAACATC CAGCGGCTCCCCAAAGAACAC
ATP5c TCAAGTCTGTTATCTCCTAC GAGGTTGGCCAGATTGTAC
Cyt c TCTCCCCAGGTGATGCCTTT CCAGCCTTCCTTCTTGGGTAT
SOD2 GTGAACAATCTCAACGCCA GATAGCCTCCAGCAACTCT
GPx1 CTCGGTTTCCCGTGCAATC CTCACCATTCACTTCGCA
Mouse b-actin CCAGCCTTCCTTCTTGGGTAT TGCTGGAAGGTGGACAGTGAG
Human b-actin AGCGGGAAATCGTGCGTGAC CGGACTCGTCATACTCCTGCT
COX I GGATTTGTTCACTGATTCCCATTA GCATCTGGGTAGTCTGAGTAGCG
COX II CAGGCCGACTAAATCAAGCAAC CTAGGACAAT GGGCATAAAG CT
COX VIIa ATGAGGGCCCTACGGGTCTC CATTGTCGGCCTGGAAGAG
cyclophilinA TTCCTCCTTTCACAGAATTATTCCA CCGCCAGTGCCATTATGG
doi:10.1371/journal.pone.0011707.t001
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ml pepstatin) (Roche) and phosphatase inhibitors (1 mM NaF and
1 mM NaVO3). Samples were incubated at 4uC for 1 h and then
centrifuged at 12,000 g for 30 min, and the supernatant was
collected for analysis. Lysates were resolved by 10% SDS-PAGE
and then transferred to PVDF membranes. The membranes were
blocked and incubated with specific antibodies against SIRT3
(Millipore), PGC-1a (Calbiochem), SOD2 (Millipore) and actin
(Sigma). Peroxidase-conjugated anti-mouse or anti-rabbit immu-
noglobulin secondary antibody was used. Proteins were visualized
by enhanced chemiluminescence.
Measurement of intracellular superoxide levels
Superoxide production was detected using the fluorescent dye
dihydroethidium (DHE) obtained from Vigorous according to a
previous study [45]. C2C12 myotubes were cultured in 6-well
plates, infected with indicated adenoviruses, and 48 h later washed
with PBS and labeled with DHE (5 mmol/L dissolved in 1%
DMSO) in the culture plates at 37uC for 30 minutes in PBS.
Culture plates were placed on ice to stop the labeling, trypsinized,
and resuspended in ice-cold PBS. Samples were analyzed using a
flow cytometer (COULTER EPICSH) and Expo32ADC software.
The mean fluorescence intensity (MFI) of 10,000 cells was
analyzed in each sample and corrected for autofluorescence from
unlabeled cells.
Mitochondrial DNA copy number
Mitochondrial DNA (mtDNA) copy number was determined as
a marker for mitochondrial density using quantitative RT-PCR as
previously reported [46,47]. Briefly, total DNA was isolated from
the cells using Universal Genomic DNA Extraction kit (Takara)
according to the manufacturer’s instructions. A serial dilution
standard curve was prepared from a pool of all the samples and
real-time PCR was carried out. The mitochondrial DNA copy
number was calculated from the ratio of COX II (mitochondrial-
encoded gene)/cyclophilin A (nuclear-encoded gene). The primers
are shown in Table 1.
Statistical Analysis
The data are reported as the mean 6 S.D. of at least three
independent experiments. Differences between groups were
compared by Student’s t test and P values,0.05 were considered
statistically significant.
Results
PGC-1a induces mouse Sirt3 gene expression
Previous studies have suggested SIRT1 directly interacts with
and deacetylates transcriptional coactivator PGC-1a [42,48].
Additionally, overexpression of SIRT3 leads to increased PGC-
1a gene expression in HIB1B brown adipocytes [35]. Both PGC-
1a and sirtuins have been demonstrated to play key roles in energy
metabolism. Therefore, we were prompted to study the association
of PGC-1a and sirtuin family members to determine if PGC-1a
affects the expression levels of sirtuin members.
Differentiated C2C12 and mouse primary hepatocytes were
infected with adenovirus expressing PGC-1a or GFP (control).
Total RNA was extracted from infected cells, and mRNAs of
sirtuin family members were measured by real-time PCR. We
observed that Sirt3 mRNA levels were increased by approximately
7-fold by PGC-1a in C2C12 myotubes compared to control cells
(Fig. 1A). In addition, PGC-1a stimulated Sirt3 mRNA level by
approximately 70-fold and 2.8-fold in mouse primary hepatocytes
and HepG2 cells, respectively (Fig. 1A). These increases in Sirt3
mRNA were accompanied by potent up-regulation of the protein
levels of mSIRT3 variants in C2C12 cells and mouse primary
hepatocytes (Fig. 1B). In contrast to Sirt3, PGC-1a did not alter
the expression of other sirtuin members (data not shown).
PGC-1a is induced in mouse liver upon fasting [7,8] and in
C2C12 cells during differentiation [46]. Thus, we speculated that
Sirt3 may be similarly regulated under these conditions. As
expected, the Sirt3 mRNA level was significantly increased in
myotubes compared to that in myoblasts (Fig. 1C), and fasting
induced Sirt3 gene expression in mouse liver (Fig. 1C). Meanwhile,
we also observed that PGC-1a was induced under these
conditions, which was consistent with previous reports.
To determine the role of PGC-1a in the regulation of Sirt3 gene
expression during these physiological processes, we employed a
siRNA strategy to specifically knock down PGC-1a gene
expression. A siRNA sequence (siPGC-1a) has been shown to
effectively silence PGC-1a gene expression [40]. Adenoviruses
expressing shRNA against PGC-1a were constructed and used to
infect C2C12 myotubes and primary hepatocytes. Knockdown of
PGC-1a in C2C12 myotubes and primary hepatocytes by siPGC-
1a reduced the expression of Sirt3 (Fig. 1D). Taken together, these
data indicate that PGC-1a functions as an upstream activator of
Sirt3 gene expression and is required for the induction of Sirt3 in
C2C12 cells and hepatocytes.
The stimulatory effect of PGC-1a on the Sirt3 promoter is
mediated by the ERR binding element located between
2407 bp and 2399 bp upstream of the Sirt3
transcription start site
To demonstrate that PGC-1a-dependent stimulation of Sirt3
gene expression occurs at the transcriptional level, we transfected a
promoter reporter into HepG2 cells. The first construct contained
the approximately 2.2-kb fragment (22036, +146) of the mSirt3
promoter fused to a luciferase reporter gene (Luc-2036) (Fig. 2A).
Overexpression of PGC-1a caused a 4-fold activation of Luc-2036
(Fig. 2B). Next, a series of truncated segments of the promoter
fused to the luciferase gene (Luc-491, Luc-242, and Luc-161) were
transfected into HepG2 cells to map the cis-acting element
conferring the PGC-1a-dependent activation of luciferase. PGC-
1a-mediated reporter activation was not significantly compro-
mised upon deletion of the 22036 bp to 2491 bp region of the
mSirt3 promoter. However, further deletion of 2491 bp to
2242 bp abolished the PGC-1a effect on the mSIRT3 promoter
(Fig. 2B). Further truncation of the promoter from 2242 bp to
2161 bp did not accentuate the process (Fig. 2B).
Next, we searched for the sequence motif in the mSirt3 gene
promoter that conferred sensitivity to PGC-1a. The sequence
between 2491 bp and 2242 bp was analyzed, and a putative
ERRE (CAAGGGCA) was revealed at position 2407/2399 bp
upstream of the transcriptional start site (Fig. 2D, left panel). In
addition, we compared this motif and its flanking sequence of the
mSirt3 promoter with corresponding promoter sequences from
different species, including rat, humans and chimpanzee. Based on
the results from sequence alignment, the putative ERR binding
site located at 2407/2399 bp is evolutionarily conserved
(Fig. 2C). PGC-1a transactivates transcription of genes involved
in oxidative phosphorylation through coactivating ERRa [49].
Thus, we hypothesized that ERRa mediates the PGC-1a
stimulatory effect on the Sirt3 promoter.
Transfection of the PGC-1a expression plasmid alone in
HepG2 cells activated Luci-2036 and Luci-491 each approxi-
mately 4-fold, and cotransfection of ERRa with PGC-1a activates
Luci-2036 and Luci-491 each approximately 9-fold, while this
SIRT3, a New Target of PGC-1a
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11707Figure 1. PGC-1a regulates the expression of SIRT3. A, Differentiated C2C12 cells (left panel), primary hepatocytes isolated from mouse liver
(middle panel) and HepG2 cells (right panel) were infected with adenoviruses expressing GFP (control) or PGC-1a. Cells were harvested 48 h after
infection, and total RNA was extracted. The mRNA levels of Sirt3 were quantified by qPCR, normalized to b-actin, and expressed relative to the GFP-
expressing control cells. B,C 2C12 myotubes and primary hepatocytes were treated as described in Panel A, and SIRT3 protein level was determined by
western blotting. Two specific bands of SIRT3 in C2C12 (left panel) and primary hepatocytes (right panel) were detected. L, long form of mSIRT3
(approximately 37 kDa). S, short form of mSIRT3 (approximately 28 kDa). C, left panel,C 2C12 myoblasts were induced to differentiate into myotubes.
Cells were harvested on day 0 (before differentiation) and day 5 (after differentiation), and total RNA was isolated. C, right panel, Total RNA was
extracted from normal or fasted mouse livers. The mRNA levels of PGC-1a and Sirt3 were quantified by qPCR, normalized to b-actin and expressed
relative to levels in the control. D, Differentiated C2C12 (left panel) and primary hepatocytes (right panel) were infected with adenovirus expressing
luciferase shRNA (siControl) or PGC-1a shRNA (siPGC-1a). Cells were harvested 48 hours after infection, and total RNA was extracted. The mRNA levels
of Sirt3 and PGC-1a were quantified by qPCR, normalized to b-actin, and expressed relative to the control cells. *, P,0.05.
doi:10.1371/journal.pone.0011707.g001
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from 2491 bp to 2242 bp (Luc-242) (Fig. 2B).
Mutational studies were further performed to investigate the
involvement of ERR in the PGC-1a activation of the mSirt3
promoter. The potential ERR binding element was mutated from
the Luc-2036 sequence (Fig. 2D, left panel), which has been
demonstrated to inactivate this element previously [50]. Wild-type
Luc-2036 and its mutant were transfected into HepG2 cells in the
presence or absence of PGC-1a and/or ERRa. We observed that
PGC-1a activated wild-type mSirt3 promoter activity and the
cotransfection of PGC-1a and ERRa enhanced this effect (Fig. 2D,
right panel). However, the transfection with ERRa expression
plasmid alone yielded no significant increase in promoter activity
(data not shown), which indicating PGC-1a and ERRa have a
synergic effect. In sharp contrast, PGC-1a activation of the mSirt3
promoter was almost completely abolished upon ERRE mutation
(Fig. 2D, right panel). These results clearly suggest that this ERRE
mediates PGC-1a activation of mSirt3 gene expression.
ERRa binds to the mSirt3 promoter and is required for
PGC-1a- induced Sirt3 expression
To determine whether ERRa binds to the potential binding
element identified in the mSirt3 gene promoter in vitro, a DNA
fragment encompassing the sequence 2386/2419 was biotin-
labeled, and EMSA was carried out using nuclear protein
extracted from 293A cells transfected with ERRa expression
Figure 2. ERRa mediates the PGC-1a activation of the Sirt3 gene promoter in HepG2 cells. A, Schematic representation of the promoter
sequence of mSirt3 (Luc-2036). Exon 1A (E1A) and exon 1B (E1B) of mSirt3 are alternatively spliced according to previous report [34]. Thus, mSirt3 has
two different transcriptional start sites. However, E1A does not encode amino acids. B,5 9-Deletion series of the mSirt3 promoter fused to luciferase
reporter gene were cotransfected into HepG2 cells together with pcDNA3.1 (control) or PGC-1a in the presence or absence of ERRa expression
plasmids. Two days later, cells were harvested and the relative luciferase activity (RLA) was corrected for Renilla luciferase activity and normalized to
the control activity. C, The nucleotide sequence from 2424 to 2366 of the mouse (Mou) Sirt3 gene promoter was aligned with corresponding
sequences from different species, including rat, humans (Hum), and chimpanzee (Chp). Evolutionarily conserved elements are indicated in large, bold,
italic type. D, left panel, Wild-type putative ERRa binding element and its mutant sequence; right panel, Reporter gene plasmid containing 2.2 kb
of the wild-type (WT) Sirt3 promoter (Luc-2036) or ERRE mutant (mut Luc-2036) were transfected into HepG2 cells together with PGC-1a in the
presence or absence of ERRa expression plasmids or empty plasmid (pcDNA3.1). The graph depicts RLA corrected for Renilla luciferase activity and
normalized to the control activity of mSirt3. All values represent at least three independent transfections, each conducted in triplicate. *, P,0.05.
doi:10.1371/journal.pone.0011707.g002
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detected, and it almost completely disappeared upon the use of
200-fold excess of unlabeled wild-type oligonucleotides. However,
200-fold excess of unlabeled mutant oligonucleotides did not affect
the formation of the DNA-protein complex (Fig. 3A).
To further confirm that ERRa binds to the Sirt3 promoter in
vivo, chromatin immunoprecipitation assays were performed. To
this end, mouse primary hepatocytes were isolated and infected
with adenoviruses expressing GFP or ERRa-FLAG in the absence
or presence of PGC-1a. Chromatin was precipitated with anti-
FLAG or normal mouse IgG (negative control). Primers were
designed to amplify a fragment of the ERRE flanking region. A
fragment of the promoter (2319/2491) was PCR amplified. As
shown in Figure 3B, the mSirt3 promoter fragment containing the
ERRE was amplified from the precipitates using FLAG-specific
antibody but not from those with normal mouse IgG in cells
infected with Ad-ERRa-FLAG. Moreover, no amplification was
observed in cells infected with Ad-GFP. It is noteworthy that
chromatin isolated from cells co-infected with Ad-PGC-1a and
Ad-ERRa-FLAG resulted in much stronger amplification of the
Sirt3 promoter containing the ERRE than that from cells infected
with Ad-ERRa-FLAG alone, indicating PGC-1a increased ERRa
binding to the Sirt3 promoter in vivo.
To determine whether endogenous PGC-1a occupies the
mSirt3 promoter region in primary hepatocytes and whether this
is dependent on the ERRE in the gene promoter, ChIP was
performed and chromatin was precipitated with anti-PGC-1a
antibody. The mSIRT3 promoter sequence containing the ERRE
(proximal region) could be amplified from the precipitates
obtained using the anti-PGC-1a antibody, but not from the
control IgG sample (Fig. 3C). As expected, the distal promoter
region without an ERRE, used as a negative control, could not be
amplified from any of the immunoprecipitates. Collectively, these
data confirm the interaction of ERRa with an ERRE identified in
the mSirt3 promoter in vivo and in vitro, and they reveal that
endogenous PGC-1a can be recruited to the proximal region
containing this ERRE.
To further determine the role of ERRa in the PGC-1a
induction of Sirt3 expression, we used siRNA oligonucleotides that
have been demonstrated to specifically knock down ERRa gene
expression [39]. As shown in Fig. 4A, ERRa knockdown
compromised the ability of PGC-1a to activate the mSirt3
Figure 3. ERRa interacts with the mouse Sirt3 promoter in vitro and in vivo.A , Electrophoretic mobility shift assay was executed using a
biotin probe. Biotin-labeled double-stranded oligonucleotides were incubated with or without nuclear extract containing ERRa protein.
Approximately 200-fold excess wild-type and ERRE-mutated unlabeled double-stranded oligonucleotides were used for competitive inhibition. B,
Primary hepatocytes were isolated, cultured in 100 mm dishes, and infected with adenoviruses expressing ERRa-FLAG and/or PGC-1a, or GFP as a
control. For ChIP, protein-DNA complexes were immunoprecipitated with anti-FLAG or control IgG antibody. The mSirt3 promoter region harboring
the ERRE site was amplified by PCR. C, Primary hepatocytes were isolated from mouse liver, and chromatin was immunoprecipitated with anti-PGC-1a
antibody. Normal IgG was used as control. The mSirt3 promoter region harboring the ERRE (proximal region) could be amplified by PCR. However,
the distal region of the mSirt3 promoter, having no ERRE and used as a negative control, could not be amplified.
doi:10.1371/journal.pone.0011707.g003
Figure 4. ERRa is required for the PGC-1a induction of Sirt3 expression. A, The full-length wild-type Sirt3 promoter fused to luciferase
reporter gene (Luc-2036) was cotransfected into HepG2 cells with pcDNA3.1 (control) or PGC-1a in the presence of shRNA against ERRa or luciferase
(control). Two days later, cells were harvested and RLA analyzed. B, Knockdown of ERRa reduced the induction of Sirt3 mRNA level by PGC-1a.C 2C12
myotubes were infected with adenoviruses expressing GFP or PGC-1a in the presence of Ad-siControl or Ad-siERRa. Total RNA was isolated 48 h later.
Sirt3 mRNA level was determined by qPCR, normalized to b-actin, and expressed relative to control cells infected with Ad-GFP and Ad-siControl. All
values represent at least three independent transfections, each conducted in triplicate. *, P,0.05.
doi:10.1371/journal.pone.0011707.g004
SIRT3, a New Target of PGC-1a
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11707promoter. Moreover, siRNA against ERRa reduced the PGC-1a
induction of endogenous mSirt3 mRNA level in C2C12 cells
(Fig. 4B). We observed that PGC-1a still stimulated Sirt3 gene
expression after knocking down ERRa, which may have resulted
from decreased but not completely abolished ERRa expression by
the siRNA. These results clearly indicate that ERRa plays an
important role in mediating the PGC-1a induction of Sirt3
expression.
Sirt3 knockdown suppresses PGC-1a-induced
mitochondrial-related gene expression
PGC-1a activates mitochondrial-related gene expression in
skeletal muscle cells, including ATP synthase and cytochrome c,
which are important components of the electron transport chain,
as well as SOD2 and GPx1, which are involved in ROS
metabolism [6]. Mouse SIRT3 is localized in the mitochondria
and associated with energy metabolism [26,35]. We wondered
whether SIRT3 mediates the PGC-1a effect on the expression of
these mitochondrial-related genes in myotubes. Adenoviruses
expressing shRNAs targeting mSirt3 were constructed. The
shRNA were expressed effectively under the control of a U6
RNA promoter. An efficient shRNA sequence (siSIRT3) for
silencing mSirt3 expression was selected from several candidates.
siSIRT3 decreased basal SIRT3 protein level by more than 60%
compared with the luciferase shRNA (negative control) (Fig. 5A).
siRNA against mSirt3 significantly suppressed the PGC-1a
induction of endogenous Sirt3 mRNA level (Fig. 5B). Therefore,
this effective siRNA was employed in the following experiments.
C2C12 myotubes were infected with various combinations of
adenoviruses. As expected, PGC-1a activated some mitochondri-
al-related genes, including ATP synthase, cytochrome c, and the
ROS-detoxifying enzymes GPx1 and SOD2. Moreover, coinfec-
tion with Ad-ERRa and Ad-PGC-1a led to further enhancement
of these gene expression levels (Fig. 5C). In contrast, PGC-1a-
induced mitochondrial gene expression was largely prevented
upon knockdown of Sirt3 in C2C12 cells (Fig. 5C). However, the
control siRNA did not affect the PGC-1a activation of these genes.
In addition, we measured SOD2 protein levels in C2C12 myotubes
infected with various combinations of adenoviruses. As shown in
Figure 5D, siSIRT3 decreased the baseline protein level of SOD2
and reduced the induction of SOD2 by PGC-1a (Fig. 5D).
Overexpression of Sirt3 in cardiomyocytes is capable of
modulating the activity of antioxidants [27]. An adenovirus
expressing the long version of mSirt3 was constructed and used
to infect C2C12 myotubes. As anticipated, overexpression of Sirt3
in C2C12 myotubes increased the mRNA levels of ATP5c and
GPx1, but not SOD2 or Cyt c. (Fig. 5E). These data demonstrate
that Sirt3 functions as a downstream target gene of PGC-1a and
mediates, at least in part, the effects of PGC-1a on the ROS
defense system.
SIRT3 mediates the effects of PGC-1a on intracellular ROS
levels and mitochondrial biogenesis
SIRT3 is localized in the inner mitochondrial membrane [32]
along with the electron transport chain. PGC-1a is suggested to be
a potent stimulator of mitochondrial biogenesis [5,6] and a
powerful regulator of ROS metabolism. Although PGC-1a
stimulates mitochondrial biogenesis and energy metabolism, it
suppresses ROS production in cells through induction of ROS-
detoxifying enzymes [14]. The mitochondrion is the major site of
superoxide formation, and the accumulation of superoxide is
believed to contribute to oxidative damage associated with
degenerative disease and aging [51]. Since knockdown of Sirt3
suppressed the PGC-1a induction of ROS-detoxifying enzymes, it
seemed logical to propose that SIRT3 mediates the PGC-1a-
dependent down-regulation of intracellular superoxide levels.
As shown in Figure 6A, the basal superoxide level was decreased
in C2C12 myotubes infected with adenovirus expressing Sirt3
compared with control cells as evaluated with ROS-activated
fluorescent dye DHE, suggesting SIRT3 plays an important role in
ROS production. Meanwhile, inhibition of endogenous PGC-1a
or SIRT3 by adenovirus expressing shRNA in C2C12 myotubes
caused an increase of cellular ROS production (Fig. 6B). In
contrast, overexpression of PGC-1a in C2C12 myotubes with
adenovirus caused a decrease of ROS production (Fig. 6C).
Interestingly, knockdown of Sirt3 gene expression with adenovi-
ruses rescued the inhibitory effect of PGC-1a on ROS production,
and the intracellular ROS level was almost completely recovered,
which suggests SIRT3 mediates the PGC-1a suppression of ROS
production in muscle cells (Fig. 6C).
We also evaluated the role of SIRT3 in the PGC-1a effect on
mitochondrial biogenesis. To measure mitochondrial DNA
directly, we isolated total DNA and determined the relative copy
number of mitochondrial DNA by a qPCR assay of the
mitochondrial DNA–encoded COX II gene. Adenovirus-mediat-
ed overexpression of SIRT3 led to an increase in mitochondrial
DNA content per cell by 1.7-fold (Fig. 7A), while inhibition of
endogenous SIRT3 by shRNA did not change the basal
mitochondrial DNA content (data not shown). As anticipated,
overexpression of PGC-1a also increased the mitochondrial DNA
copy number (Fig. 7B). Furthermore, knockdown of endogenous
mSIRT3 reduced the induction of mitochondrial biogenesis by
PGC-1a (Fig. 7B). In addition, mRNA transcript levels of
cytochrome c oxidase (COX) subunits I and II (mitochondrial-
encoded) and subunit VIIa (nuclear- encoded) were induced by
PGC-1a (Fig. 7C). Knockdown of endogenous mSIRT3 blocked
the PGC-1a effect on COX I, COX II and COX VIIa1 gene
expression (Fig. 7C). These results reveal the important physio-
logical role of SIRT3 in mitochondrial biogenesis.
Previous work has suggested overexpression of SIRT3 in brown
adipocytes leads to increased CREB phosphorylation, subsequent
stimulation of the expression of PGC-1a and its target gene UCP1,
and, ultimately, decreased intracellular ROS level [35]. Another
study demonstrated that PGC-1a suppresses ROS production
through the induction of ROS-detoxifying enzymes [14]. Finally,
SIRT3 interacts with and deacetylates Foxo3a to activate its target
gene SOD2 in cells [27]. Based on these data and our
observations, we propose a model of the mechanism of SIRT3
action on ROS production and mitochondrial biogenesis (Fig. 8).
In this model, SIRT3 stimulates PGC-1a gene expression through
increased CREB phosphorylation. Meanwhile, PGC-1a induces
SIRT3 expression through ERRa, thus forming a positive-
feedback loop. In addition to suppression of basal ROS production
in cells, our data clearly demonstrate that SIRT3 mediated the
PGC-1a induction of ROS-detoxifying enzymes and reduction of
ROS level. Finally, our results also reveal a physiological role for
SIRT3 in mitochondrial biogenesis.
Discussion
Sirtuins are NAD
+-dependent enzymes that have been impli-
cated in a wide range of physiological and pathophysiological
conditions, including diabetes, cancer, life span and neurodegen-
eration, through deacetylation of numerous substrates [52]. Seven
mammalian sirtuin members have been identified to date. One
well-studied sirtuin, SIRT1, is reported to interact with and
deacetylate PGC-1a to increase its activity, subsequently leading
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mitochondrial oxidative phosphorylation and fatty acid oxidation
in muscle cells [42,48].
SIRT3 is a soluble mitochondrial protein controlling global
mitochondrial protein acetylation levels. Sirt3 knockout mice show
striking mitochondrial protein hyperacetylation [25]. Further-
more, SIRT3 deacetylates AceCS2, GDH, Fox3a and Ku70 to
regulate their activity [23,24,25,27,28,29]. These observations
implicate SIRT3 in the regulation of energy metabolism. Thus, we
decided to further investigate the association between PGC-1a and
sirtuin members.
Our data suggest that PGC-1a stimulates SIRT3 expression at
the mRNA and protein levels. We did not observe an effect of
PGC-1a on other sirtuins. PGC-1b, another member of the PGC-
1 family, mildly stimulated SIRT3 gene expression (approximately
2-fold) in C2C12 cells (data not shown), much less effectively than
PGC-1a. We speculate that PGC-1b also activates Sirt3
transcription through the ERRE identified in the mSirt3 gene
Figure 5. SIRT3 mediates the PGC-1a induction of mitochondrial-related genes in C2C12 skeletal muscle cells. A, Knockdown of mSIRT3
protein level with shRNA in C2C12 myotubes. C2C12 cells were induced to differentiate into myotubes and infected with adenovirus expressing either
control shRNA (siControl) or SIRT3 shRNA (siSIRT3). Cells were harvested 48 h after infection, and protein was extracted for western blotting with the
indicated antibodies. B, mSirt3 mRNA level was reduced by shRNA against mSirt3 in C2C12 myotubes. C2C12 myoblasts were induced into myotubes
and infected with the indicated adenovirus expressing siSIRT3 or siControl, in the presence of Ad-GFP or Ad-PGC-1a and/or Ad-ERRa. Total RNA was
extracted 48 h after infection, and Sirt3 mRNA level was determined by qPCR, normalized to b-actin, and expressed relative to control cells infected
with Ad-GFP. C, Knockdown of SIRT3 decreases the PGC-1a induction of mitochondrial-related gene expression. C2C12 cells were treated as described
in Panel B. The mRNA levels of SOD2, GPx1, ATP5c and Cyt c were measured by qPCR. D,C 2C12 cells were treated as described in Panel B. The protein
levels of SOD2 were determined by western blotting. E, Overexpression of SIRT3 increased the mRNA levels of GPx1 and ATP5c. C2C12 myotubes were
infected with adenoviruses expressing GFP or long-form mSIRT3. Cells were harvested and total RNA was extracted 48 h after infection. The mRNA
levels of GPx1 and ATP5c were measured by qPCR, normalized to b-actin, and expressed relative to control cells infected with Ad-GFP. Values
represent the mean of three independent experiments performed in triplicate. *, P,0.05.
doi:10.1371/journal.pone.0011707.g005
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stimulate downstream target genes [20].
Current studies of SIRT3 mainly focus on its cellular
localization and identification of its substrates. However, the
molecular mechanism regulating Sirt3 gene expression remains
unknown. Our data demonstrate the existence of a regulatory
pathway that drives mitochondrial ROS generation and mito-
chondrial biogenesis that is defined by PGC-1a, ERRa and
SIRT3. This is supported by the following evidence: First, PGC-
1a increased the expression of SIRT3 mRNA and protein. PGC-
1a knockdown by shRNA reduced Sirt3 mRNA level. Second, the
stimulatory effect of PGC-1a depended on the intact ERR binding
site in the mSirt3 promoter, and cotransfection of PGC-1a and
ERRa had a synergic effect on mSIRT3 promoter activity.
Interestingly, overexpression or inhibition of ERRa had no effect
on Sirt3 promoter activity or mRNA level in the absence of PGC-
1a, leading us to conclude that ERRa contributes to the PGC-1a-
mediated induction but not the basal expression of Sirt3. Third,
EMSA and ChIP demonstrated ERRa binding to the ERRE
identified in the Sirt3 promoter in vitro and in vivo, and PGC-1a
further enhanced ERRa binding to the Sirt3 promoter in vivo.
Fourth, induction of mitochondrial-related gene expression,
including the ROS-detoxifying enzymes SOD2 and GPx1, by
PGC-1a was impaired by Sirt3 knockdown in C2C12 myotubes.
Fifth, knockdown of SIRT3 diminished the effect of PGC-1a on
cellular ROS level and mitochondrial biogenesis. Finally, PGC-1a
action explains the stimulatory effect of C2C12 differentiation and
nutrient treatment in mice on Sirt3 expression. Taken together,
Figure 6. SIRT3 controls intracellular ROS levels. A,C 2C12 myotubes were infected with adenovirus expressing GFP or SIRT3. DHE (5 mM) was
added to media 30 min before collecting cells. The cells were harvested and immediately analyzed with a flow cytometry, and data were processed
with Expo 32ADC software. The histogram overlays showed overexpression of mSIRT3 reduced the cellular ROS level. B, Knockdown of PGC-1a or
SIRT3 increased cellular ROS level. C2C12 myotubes were treated with the indicated adenovirus (Ad-siControl, Ad-siPGC-1a or Ad-siSIRT3), treated with
DHE, and analyzed with a flow cytometry as described in panel A. C, Overexpression of PGC-1a decreased cellular ROS level, and knockdown of SIRT3
blocked the inhibitory effect of PGC-1a on ROS production. C2C12 myotubes were treated with the indicated adenovirus (Ad-GFP, Ad-PGC-1a, Ad-
siControl, or/and Ad-siSIRT3), treated with DHE, and analyzed with a flow cytometer as described in panel A. x-Axis, fluorescence intensity showing
the extent of DHE oxidation; y-axis, cell number. The image is representative of three experiments. Right panels, Flow cytometry analysis of
myotube cells. Values represent the mean of four independent experiments performed in duplicate. MFI, mean fluorescent intensity. *, P,0.05.
doi:10.1371/journal.pone.0011707.g006
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PGC-1a and that SIRT3, at least in part, mediates the effects of
PGC-1a on mitochondrial metabolism.
Mitochondria are a major source of superoxide formed by the
reaction of respiratory chain enzymes with molecular oxygen.
PGC-1a stimulates mitochondrial energy metabolism and mito-
chondrial biogenesis through coactivation of several transcription
factors. PGC-1a increases the expression of most, if not all,
mitochondrial proteins, which could cause an increase of ROS
production. However, PGC-1a can induce the expression of genes
reducing ROS formation [6,53,54]. St-Pierre et al. reported that
PGC-1a is required for the induction of ROS-detoxifying enzymes
under oxidative stress conditions and that PGC-1a–null mice are
more sensitive to oxidative stress affecting the hippocampus [14].
Our data demonstrate that PGC-1a is a suppressor of ROS
generation in skeletal muscle cells by increasing the expression of
GPx1 and SOD2. We also show that knockdown of endogenous
SIRT3 expression led to an increase of cellular ROS level and that
overexpression of SIRT3 decreased the ROS level, indicating that
SIRT3 acts as suppressor of ROS formation like PGC-1a in vivo
and mediates the effect of PGC-1a on cellular ROS production.
These results are consistent with a previous report that constitutive
expression of SIRT3 reduces ROS production in brown
adipocytes [35]. Longevity is a complex phenomenon, and the
sirtuins have been shown to play a role in the genetic regulation of
longevity. Of interest, it has been reported that polymorphism in
Figure 7. SIRT3 mediates the PGC-1a induction of mitochondrial biogenesis in C2C12 myotubes. A, SIRT3 overexpression stimulated
mitochondrial biogenesis. C2C12 myotubes were infected with Ad-GFP or Ad-SIRT3. Cells were harvested 48 h after infection, and the DNA level of the
mitochondrial-encoded COX II gene was measured by qPCR, normalized to DNA levels of the nuclear-encoded gene cyclophilin A, and expressed
relative to levels in control cells expressing GFP, which were set to 1. B, Knockdown of SIRT3 inhibited the induction of mitochondrial biogenesis by
PGC-1a.C 2C12 myotubes were infected with the indicated adenovirus (Ad-GFP, Ad-PGC-1a, Ad-siControl, or/and Ad-siSIRT3). Mitochondrial DNA copy
number was measured as described in panel A. C, Knockdown of SIRT3 inhibited the induction of mRNA level of COX I, COX II and COX VIIa by PGC-
1a.C 2C12 myotubes were infected with the indicated adenovirus (Ad-GFP, Ad-PGC-1a, Ad-siControl, and/or Ad-siSIRT3). Cells were harvested and
total RNA was extracted 48 h after infection. The mRNA levels of mitochondrial-encoded (COX I and COX II) and nuclear-encoded (COX VIIa) subunits
of COX were measured by qPCR, normalized to b-actin, and expressed relative to control cells infected with Ad-GFP and Ad-siControl. Values
represent the mean of three independent experiments performed in duplicate. *, P,0.05.
doi:10.1371/journal.pone.0011707.g007
Figure 8. Scheme illustrating a regulatory pathway including
PGC-1a and SIRT3 governing ROS level and mitochondrial
biogenesis. PGC-1a coactivates ERRa to stimulate the expression of
mSIRT3, which, in turn, increases the expression of the ROS-detoxifying
enzymes GPx1 and SOD2 to suppress the ROS levels. Meanwhile,
ectopic expression of SIRT3 leads to an increase of CREB phosphory-
lation, which subsequently stimulates the expression of PGC-1a and its
target gene UCP1, finally decreasing intracellular ROS level. SIRT3 is also
involved in mitochondrial biogenesis.
doi:10.1371/journal.pone.0011707.g008
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hSIRT3 is identified as a cell survival factor that protects cells from
genotoxic stress [55]. However, less is currently known about the
mechanism of SIRT3-mediated cell protection during stress. Our
results suggest that SIRT3 can inhibit the formation of ROS,
which are implicated in aging and cancer. Thus, we speculated
that the functional role of SIRT3 in longevity and cell survival
contributes to its suppression of the ROS level.
PGC-1a induces mitochondrial biogenesis through coactivation
of NRF-1 and NRF-2 to increase mitochondrial transcription
factor A (mtTFA) [5]. We found that inhibition of SIRT3
expression by shRNA diminished the PGC-1a induction of
mitochondrial biogenesis. A possible explanation is that NRF-1
and mtTFA, which localize to mitochondria, are also substrates of
SIRT3 and their activities are regulated by SIRT3. Further studies
are required to determine the molecular mechanism by which
SIRT3 controls mitochondrial biogenesis. SIRT3-null mice
exhibit mitochondrial protein hyperacetylation [25] and reduced
basal levels of ATP in the heart, kidney and liver tissues [26], but
these reports did not indicate whether mitochondrial DNA
number is reduced in these tissues of Sirt3-knockout mice. In this
study, we also provide evidence that SIRT3 is necessary for PGC-
1a induction of Cyt c and ATP synthase, both of which are key
components of the electron transport chain. It is logical to propose
that SIRT3 participates in lipid acid oxidation and mitochondrial
oxidative phosphorylation.
Human SIRT3 has two different forms, a full-length protein
(approximately 44 kDa) and a shorter, active form (approximately
28 kDa) lacking the N-terminal 142 amino acids [33,56].
However, the molecular weight of mouse SIRT3 is controversial.
Sundaresan et al. reported that the full-length mSIRT3 protein
(precursor) is 44 kDa [28], while Cooper et al. and Jin et al.
reported that the longer variant should be 37 kDa [36,37]. Since
the long variant of mSIRT3 consists of 334 amino acids, we
calculate that the longer variant should be 37 kDa. Our western
blot results confirmed that there were two forms of endogenous
mSIRT3 (37 kDa and 28 kDa) detected by the antibody
recognizing the C-terminus of mSIRT3.
In addition, the subcellular localization of SIRT3 also remains
controversial. Initial studies suggested that full-length and
processed forms of hSIRT3 are localized in mitochondria
[32,33], but another study indicated that full-length hSIRT3 is
localized in the nucleus and that processed forms are localized in
the mitochondria [56]. Mouse SIRT3 was originally identified to
be localized in the mitochondria [35]; in contrast, another recent
study showed that the full-length form of mSIRT3 is present in the
mitochondria and the 28-kDa form is detectable in the
mitochondria, nucleus and cytoplasm [36,37]. We detected
mSIRT3 protein in both nucleus and mitochondria in C2C12
cells, and both nuclear and mitochondrial mSIRT3 were induced
by PGC-1a (data not shown).
Overexpression of SIRT3 in brown adipocytes activates CREB
phosphorylation, resulting in stimulation of PGC-1a and UCP1
gene expression, consequently decreasing the cellular ROS level.
Another recent study reported that SIRT3 can deacetylate Foxo3a
to activate its target gene SOD2 [27,29]. In addition, PGC-1a
suppressed ROS production through induction of ROS-detoxify-
ing enzymes [14]. We summarize these results and propose a
model of the mechanism of SIRT3 action on ROS production and
mitochondrial biogenesis. As shown in Figure 8, PGC-1a induces
SIRT3 expression through coactivation of ERRa, and in turn,
SIRT3 stimulates PGC-1a gene expression through activation of
CREB phosphorylation, thus forming a positive-feedback loop. In
addition to suppression of basal ROS production in cells, SIRT3
mediates the induction of ROS-detoxifying enzymes and reduc-
tion of ROS level by PGC-1a. Finally, our results also reveal the
physiological role of SIRT3 in mitochondrial biogenesis.
ROS-related damage has been implicated in cancer, aging,
diabetes, and neurodegenerative diseases, and SIRT3 plays
important roles in reducing cellular ROS level. As a regulatory
enzyme, SIRT3 may be used as a therapeutic target to treat these
ROS-related diseases.
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